Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed COO
Appointed director
|
|
VERACYTE, INC. (VCYT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/17/2014 |
8-K
| Appointed COO|
Docs:
|
"Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer South San Francisco, Calif. — September 17, 2014 — Veracyte, Inc. , a molecular diagnostics company pioneering the field of molecular cytology, today announced the promotion of Christopher M. Hall to chief operating officer. Mr. Hall joined Veracyte in 2010 as chief commercial officer to spearhead the company's commercial entry into endocrinology. Since 2012, he has led sales, marketing, laboratory and customer service operations, as well as managed care and billing functions. As chief operating officer, Mr. Hall will also lead the business strategy for Veracyte's products in endocrinology and pulmonology, and will assume a greater role with investor relations and corporate strategy. “Chris's strategic and..." |
|
|
|